Form 4 for CRL Charles River Laboratories
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001127602-24-002840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-31 | 2024-01-29 | CRL | Girshick Birgit | COO, Corp. Executive VP | F - Tax | $220.28 | -1,159 | 48.1K | -2% | -$255.3K | |
| 2024-01-31 | 2024-01-29 | CRL | Girshick Birgit | COO, Corp. Executive VP | A - Grant | $0.00 | +3,526 | 49.3K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | F | D | 1,159 | $220.28 | 48,115 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-29 | A | A | 3,526 | $0.00 | 49,274 | D | — | — | (F1) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. |